Pain relief after abdominal surgery: testing HSK55718 against morphine and placebo
Official title: A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HSK55718 Injection for Postoperative Pain Treatment in Abdominal Surgery
Run by Haisco Pharmaceutical Group Co., Ltd. · NCT07533786 · Data updated 2026-11-12
We’re testing whether HSK55718 can safely and effectively reduce pain after abdominal surgery, compared with morphine and a placebo.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. Industry-sponsored |
| Locations | 2 sites (Changsha, Hunan and 1 other locations) |
| Status | Recruiting |
| Started | May 22, 2026 |
| Main results expected | November 22, 2026 |
| Study ends | November 22, 2026 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT07533786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) undergoing abdominal surgery under general anesthesia with postoperative pain (NRS ≥ 4) within 4 hours after surgery, and who meet ASA I–III without contraindicating conditions.
✕Probably not a fit
Patients with certain comorbidities, recent or ongoing opioid use, or other conditions listed in the exclusion criteria may not benefit or could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized, double-blind study enrolling about 200 adults who have undergone abdominal surgery under general anesthesia. Participants will be assigned to receive one of three treatments: HSK55718 at one of three dose levels, placebo, or morphine, in a double-dummy design. The trial aims to compare pain relief and safety outcomes in the early postoperative period, with NRS pain scores used to guide assessments. Eligible participants must be adults with BMI between 18 and 30, ASA I–III, and active pain within 4 hours after surgery. The study will be conducted at two Chinese hospitals, with lead sponsor Haisco Pharmaceutical Group Co., Ltd.
Why it matters
Potential benefit: If successful, patients may experience better pain control with a favorable safety profile after abdominal surgery.
How similar studies have gone: Evidence from similar analgesic trials suggests potential for improved pain control with alternative analgesics, though each drug profile is unique.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old, regardless of gender; * 18 kg/m2≤BMI≤30 kg/m2; * American Society of Anesthesiologists (ASA) gradeⅰ-ⅲ; * Accept abdominal surgery under general anesthesia; * Within 4 hours after the end of surgery, NRS≥4 in the resting state at any time; * Fully understand and voluntarily participate this trial, and sign the informed consent form; Exclusion Criteria: * A history of cardiovascular, respiratory, neurological, or psychiatric diseases that meet the protocol-defined exclusion criteria. * Clinically significant abnormalities in laboratory tests during the screening period. * A history of severe drug allergy or known allergy to the investigational drug. * Continuous use of opioid analgesics for more than 10 days for any reason within 3 months prior to randomization. * Use of any medication that may affect analgesia, where the last dose was administered less than 5 half-lives of that drug before randomization. * A history of drug abuse, substance abuse, and/or alcohol abuse within the past year. * Pregnant or lactating women. * Participation in another drug clinical trial within 3 months prior to the screening period. * Presence of any sensory dysfunction. * Presence of any painful physical condition. * Subjects with any other factor considered by the investigator to be ineligible for participation in the trial.
Where it's running
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Yongrui Wang
- Email: wangyr@haisco.com
- Phone: 028-67258779
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if virtual reality headsets can help with pain and anxiety after open-heart surgery
This randomized trial tests whether using virtual reality headsets after open-heart surgery reduces pain and anxiety and improves satisfaction and physiological measures compared with standard care.
-
Post-Operative Pain Relief with Zynrelef vs Periarticular Injections in Robot-Assisted Knee Replacement
This study tests whether the Zynrelef extended-release periarticular injection can reduce pain and opioid use after robot-assisted total knee arthroplasty compared with standard periarticular injections.
-
Virtual reality to reduce pain and anxiety during first-trimester procedural abortion
This trial will test whether wearing a VR headset that shows a meditative nature video during a first-trimester procedural abortion reduces pain and anxiety and increases satisfaction compared with usual care.
-
Tegileridine for postoperative pain after adolescent scoliosis surgery
This trial tests whether Tegileridine can provide pain relief after spine surgery in teens as well as morphine, using a patient-controlled pump and comparing safety profiles.
-
Lowering opioid use before spine surgery
This pilot test tries two tapering approaches for adults who take daily opioids and have spine surgery scheduled at least four weeks away—education alone versus education plus two CBT sessions—to see which helps them reduce opioids by the time of surgery.
-
Mindfulness to support recovery after colorectal surgery
This study will try teaching adults having colorectal surgery simple mindfulness exercises to help them feel calmer and manage pain after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.